Nishadil
Nishadil Ads Nishadil Astrology Nishadil Developers Nishadil Domains Nishadil Drive Nishadil Finance Nishadil Pay Nishadil Weather Nishdil Calendar Rewards
Signup Signin
Washington | 25°C (overcast clouds)
Topic Feed

FdaApproval

Showing the latest stories and updates for this topic.
A Game Changer? Wockhardt's Zaynich Secures Landmark US FDA Nod for Stubborn UTIs

A Game Changer? Wockhardt's Zaynich Secures Landmark US FDA Nod for Stubborn UTIs
Boehringer Ingelheim’s Survodutide Shows Promise in Late‑Stage Obesity Trials

Boehringer Ingelheim’s Survodutide Shows Promise in Late‑Stage Obesity Trials
Dexcom’s New G7 CGM Shows Real‑World Benefits for Type 2 Diabetes

Dexcom’s New G7 CGM Shows Real‑World Benefits for Type 2 Diabetes
AkeSO’s Lung‑Cancer Drug Shows a Survival Edge Over the Current Standard

AkeSO’s Lung‑Cancer Drug Shows a Survival Edge Over the Current Standard
Mobia Medical's Rocky Start: Navigating the Treacherous Waters of Stroke Treatment

Mobia Medical's Rocky Start: Navigating the Treacherous Waters of Stroke Treatment
Mifepristone and the Courts: Decoding the Abortion Pill's Legal Rollercoaster

Mifepristone and the Courts: Decoding the Abortion Pill's Legal Rollercoaster
The Unfolding Legal Battle Over Mifepristone: A Closer Look at America's Most Common Abortion Pill

The Unfolding Legal Battle Over Mifepristone: A Closer Look at America's Most Common Abortion Pill
A New Era for Hearing: Gene Therapy Approved for Inherited Deafness

A New Era for Hearing: Gene Therapy Approved for Inherited Deafness
UCLA Shines as FDA Approves Groundbreaking Gene Therapy for Children

UCLA Shines as FDA Approves Groundbreaking Gene Therapy for Children
A New Dawn for Weight Loss? FDA Greenlights Game-Changing Oral GLP-1 Pill!

A New Dawn for Weight Loss? FDA Greenlights Game-Changing Oral GLP-1 Pill!
A New Chapter in Lupus Nephritis Care: Aurinia's Breakthrough

A New Chapter in Lupus Nephritis Care: Aurinia's Breakthrough
A New Dawn for Fragile Lives: Abeona Therapeutics' Zevaskyn Revenue Signals a Profound Shift

A New Dawn for Fragile Lives: Abeona Therapeutics' Zevaskyn Revenue Signals a Profound Shift
Sarepta's Shares Climb as Critical Safety Study for Elevidys Gene Therapy Kicks Off

Sarepta's Shares Climb as Critical Safety Study for Elevidys Gene Therapy Kicks Off
ImmunityBio's Stock Plunge: Can Dr. Soon-Shiong's Cancer Science Convince Skeptical Investors?

ImmunityBio's Stock Plunge: Can Dr. Soon-Shiong's Cancer Science Convince Skeptical Investors?
The Ozempic War is Over: What the Novo Nordisk and Hims & Hers Settlement Means for Your Access to GLP-1s

The Ozempic War is Over: What the Novo Nordisk and Hims & Hers Settlement Means for Your Access to GLP-1s
A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval

A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval
A Stinging Setback: Incyte's Cancer Therapy Fails to Clear FDA's High Bar

A Stinging Setback: Incyte's Cancer Therapy Fails to Clear FDA's High Bar
The Shifting Sands of Pharma: FDA's Grip, Global Ambitions, and the Future of Medicine

The Shifting Sands of Pharma: FDA's Grip, Global Ambitions, and the Future of Medicine
A Legal Storm Brews: Sarepta's Groundbreaking Muscular Dystrophy Therapy Faces Renewed Patent Challenge

A Legal Storm Brews: Sarepta's Groundbreaking Muscular Dystrophy Therapy Faces Renewed Patent Challenge
A New Horizon for Schizophrenia Treatment

A New Horizon for Schizophrenia Treatment
Moderna's Ambitious mRNA Flu Vaccine Hits a Regulatory Snag

Moderna's Ambitious mRNA Flu Vaccine Hits a Regulatory Snag
A New Era for Flu Protection? Moderna's mRNA Vaccine on the Horizon

A New Era for Flu Protection? Moderna's mRNA Vaccine on the Horizon
Weight-Loss Drug Wars Escalate: Novo Nordisk Sues Hims & Hers Over Compounded Semaglutide

Weight-Loss Drug Wars Escalate: Novo Nordisk Sues Hims & Hers Over Compounded Semaglutide
Hims & Hers' Super Bowl Cancer Test Ad Sparks Heated Debate Over Reliability and Ethics

Hims & Hers' Super Bowl Cancer Test Ad Sparks Heated Debate Over Reliability and Ethics
A Pivotal Moment: Protalix Biotherapeutics Stands on the Cusp of a Game-Changing Decision for Elfabrio

A Pivotal Moment: Protalix Biotherapeutics Stands on the Cusp of a Game-Changing Decision for Elfabrio
Legend Biotech's Carvykti: A Beacon of Hope Reshaping Multiple Myeloma Treatment

Legend Biotech's Carvykti: A Beacon of Hope Reshaping Multiple Myeloma Treatment
Prime: Unlocking a Brighter Future for Wilson's Disease and Beyond

Prime: Unlocking a Brighter Future for Wilson's Disease and Beyond
A New Dawn in Oncology: Grail's Quest for Multi-Cancer Early Detection

A New Dawn in Oncology: Grail's Quest for Multi-Cancer Early Detection
FDA Approval for Cytokinetics' Aficamten: A Scientific Triumph, But Wall Street Remains Wary

FDA Approval for Cytokinetics' Aficamten: A Scientific Triumph, But Wall Street Remains Wary
Cytokinetics' Myqorzo Secures Landmark FDA Approval, Reshaping HCM Treatment Landscape

Cytokinetics' Myqorzo Secures Landmark FDA Approval, Reshaping HCM Treatment Landscape
A Beacon of Hope and a Stock Market Phenomenon: The Capricor Therapeutics Story

A Beacon of Hope and a Stock Market Phenomenon: The Capricor Therapeutics Story
Axogen's Avance Nerve Graft Achieves Historic FDA Biologics License Approval

Axogen's Avance Nerve Graft Achieves Historic FDA Biologics License Approval
Eli Lilly's Jaypirca Secures Full FDA Approval, Offering New Hope for Certain Blood Cancers

Eli Lilly's Jaypirca Secures Full FDA Approval, Offering New Hope for Certain Blood Cancers
Citius Oncology's Lymphir: A New Chapter in the Fight Against Cutaneous T-Cell Lymphoma

Citius Oncology's Lymphir: A New Chapter in the Fight Against Cutaneous T-Cell Lymphoma
A New Dawn for Skin Cancer Patients: Citius Oncology Launches Lymphir in the US

A New Dawn for Skin Cancer Patients: Citius Oncology Launches Lymphir in the US
A Game-Changer for Kids' Eyes: New FDA-Approved Glasses Tackle Nearsightedness Head-On

A Game-Changer for Kids' Eyes: New FDA-Approved Glasses Tackle Nearsightedness Head-On
A Welcome Return: FDA Gives Green Light to Reformulated Ranitidine (Zantac) After Major Recall

A Welcome Return: FDA Gives Green Light to Reformulated Ranitidine (Zantac) After Major Recall
A New Horizon for SMA Patients: Novartis's Groundbreaking Gene Therapy Gets FDA Nod

A New Horizon for SMA Patients: Novartis's Groundbreaking Gene Therapy Gets FDA Nod
Novartis Shares Soar as FDA Gives Landmark Nod to Zolgensma Gene Therapy for Teens and Adults

Novartis Shares Soar as FDA Gives Landmark Nod to Zolgensma Gene Therapy for Teens and Adults
A New Horizon for Bladder Cancer Patients: FDA Approves Keytruda-Padcev Combo as First-Line Therapy

A New Horizon for Bladder Cancer Patients: FDA Approves Keytruda-Padcev Combo as First-Line Therapy
The Sound Revolution: Your AirPods Just Became So Much More Than Headphones

The Sound Revolution: Your AirPods Just Became So Much More Than Headphones
The Siren Song of 'Secret' Serums: Why Influencer-Pushed Peptides Could Be Perilous

The Siren Song of 'Secret' Serums: Why Influencer-Pushed Peptides Could Be Perilous
The Market's Whispers: Unpacking Today's Corporate Buzz

The Market's Whispers: Unpacking Today's Corporate Buzz
Load more..